Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippi applies for you, and finds you a job.
WindMIL Therapeutics received early financing of $10.0M on 2016-04-07.
| Series | Round size | Date |
|---|---|---|
| Series A | $10M | 04/2016 |
| Series B | $32.5M | 06/2018 |
| Investors | Security type |
|---|---|
| Scott H. Cohen | Series A |
| Medivate Partners LLC | Series B |
| Camden Partners | Series B |
| FoxKiser LLP | Series B |
| Qiming Venture Partners | Series B |
| Domain Associates | Series B |
Zippia gives an in-depth look into the details of WindMIL Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about WindMIL Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at WindMIL Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by WindMIL Therapeutics. The data presented on this page does not represent the view of WindMIL Therapeutics and its employees or that of Zippia.
WindMIL Therapeutics may also be known as or be related to WindMIL Therapeutics, WindMIL Therapeutics Inc and WindMIL Therapeutics, Inc.